The direct injection of semicarbazide (SC), an antivitamin B6 (anti-B6), into the lateral ventricle of the mouse brain induced convul sion and tremors at a smaller dose after a shorter latent period than that in systemic administration. The symptoms were prevented by pyri doxine, aminooxyacetic acid or acetone, while they enhanced by pyridoxal, pyridoxal phosphate, or some other anti-B6. In mice fed a vitamin B6 (B6)-deficient diet, convulsion and tremors occurred at smaller doses of SC than those in mice given control food, and were counteracted by pyridoxine. On the other hand, mice into which SC had been inject ed in the neighboring site of the lambda first showed running fits, which was followed by convulsion and tremors.
Summary
The direct injection of semicarbazide (SC), an antivitamin B6 (anti-B6), into the lateral ventricle of the mouse brain induced convul sion and tremors at a smaller dose after a shorter latent period than that in systemic administration. The symptoms were prevented by pyri doxine, aminooxyacetic acid or acetone, while they enhanced by pyridoxal, pyridoxal phosphate, or some other anti-B6. In mice fed a vitamin B6 (B6)-deficient diet, convulsion and tremors occurred at smaller doses of SC than those in mice given control food, and were counteracted by pyridoxine. On the other hand, mice into which SC had been inject ed in the neighboring site of the lambda first showed running fits, which was followed by convulsion and tremors. 
RESULTS
Effect of injection of SC on mice Mice exhibited tonic and clonic convulsions and tremors following a latent period of about 15min after the injection of SC (Table 1) . Such violent behavior as dashing, jumping, and leaping often occurred about 15min thereafter. These manifestations resembled those induced by systemic administration of SC, but running fits, which is a characteristic behavior induced by SC and other many anti-B6 when administered systemically, was not observed. Antidotal effect of B6, acetone, or aminooxyacetic acid on SC-induced convulsion Convulsion and tremors were prevented when pyridoxine (i.p. or i.c.) was administered simultaneously with SC. The antidotal effect was not afforded by pyridoxamine or pyridoxamine phosphate. Administration of either pyridoxal or pyridoxal phosphate had an augmentative rather than preventive effect on the convulsive symptoms; incidence of convulsions increased. Pyridoxal phosphate, however, did not produce convulsion in mice treated with SC at subconvulsive doses (Table 2) . Acetone and aminooxyacetic acid were effective antidotes for SC toxicity (Table 3) .
Effect of SC on acute or chronic Bs-deficient mice Some mice were given SC, thiosemicarbazide, isoniazide, DL-penicillamine, 4-deoxypyridoxine, toxopyrimidine, or castrix at subconvulsive doses to acutely deprive them of B6. Administration of SC (i.p.), isoniazide (i.c.), DL-penicillamine (i.c.), 4-deoxypyridoxine (i.c.), or toxopyrlmldlne (i.c.) induced convulsion when followed by injection of subconvulsive dose of SC. Neither thiosemicarbazide, nor castrix enhanced SC toxicity (Table 3) .
Mice fed on B6-deficient diet (Clea Japan, Co.) for one or three weeks after four weeks of age showed high susceptibility to SC: convulsion and tremors were induced by SC at small doses which were ineffective in those fed on control diet. These symptoms were countered with the administration of a pyridoxine antidote (Table 4) . Table  6 ). The fits were often followed by tonic and clonic convulsions, and tremors 10-60min thereafter.
DISCUSSION
The direct injection of a reagent into the lateral ventricle is considered to in flict a severe mechanical injury to the brain. The method, however, would simplify the induced phenomenon at least in comparison with systemic admin istration. The present experiment indicates that intracerebral injection of SC at considerably small doses reduces the latent period of the first symptom as com pared with the data reported on the study of systemic administration of SC and many other anti-B6 (3), and also of intracerebral administration of other anti-B6 (2). This finding might deserve attention, because research on the mode of action of massive doses of convulsants administered systemically has been complicated by diverse physiological and biochemical changes of the brain during that long latency.
Since JENNEY and LEE'S results were published (4), it is well known that systemic administration of SC induces tonic and clonic convulsions as well as running fits, which are inhibited by acetone (4), pyridoxine (5), or aminooxyacetic acid. The present study revealed that intracerebral injection of SC induced similar convulsions to those by systemic administration, which were also countered by acetone, pyridoxine, or aminooxyacetic acid antidotes. Moreover, the con vulsions were enhanced by some anti-B6, besides mice fed on B6-deficient diet were more sensitive to SC than to controls. It appears likely that symptoms produced by intracerebral injection of SC are due essentially to mechanisms com mon to those by SC and other many anti-Bfl administered systemically.
It is not clear why both pyridoxal and pyridoxal phosphate augmented con vulsion in mice receiving SC, while pyridoxine prevented convulsion. The hypo thetical explanation is that only pyridoxine itself has an antidotal effect on SC convulsion or that pyridoxal and pyridoxal phosphate made from pyridoxine in vivo are effective, but exogenous ones are not. And both exogenous pyridoxal and pyridoxal phosphate appear to be toxic rather than anticonvulsant substances. This assumption is consistent with the report that pyridoxal phosphate (i.c.) alone is a convulsant in mice (6) .
Because pyridoxal kinase is inhibited in vitro by SC and severely by semi carbazone of pyridoxal (7), it is conceivable that the combination of SC with pyridoxal and/or pyridoxal phosphate is responsible for the induction of the con vulsive phenomena. This is plausibly supported by the present experimental result that small doses of semicarbazone of pyridoxal phosphate (i.c.) induced convulsion and tremors similar to those by SC.
SC injected in the vicinity of lambda, 2-5mm below the skull, produced running fits which was often followed by tonic and clonic convulsions and tremors 10-60min thereafter. Considering this result, the data obtained from the in jection of SC into the lateral ventricle, and the fact that systemic administration of SC induces convulsion, tremors, and also running fits, SC seems to act upon two (or more) sites of the brain; one related to convulsion and tremors, and the other to running fits. The former appears likely to be adjacent to the lateral ventricle or the site where SC penetrates with facility from the lateral ventricle. The latter is assumed to be the midbrain, judging from the sites of administration. And the difference between the latent periods of systemic and intracerebral ad ministration is presumed to relate to the time of penetration of SC into the target loci of the brain.
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